6,10-Methano-6H-pyrazino[2,3-h][3]benzazepine, 7,8,9,10-tetrahydro-8-(trifluoroacetyl)- (9CI)
![BK034N | 230615-70-0 | 6,10-Methano-6H-pyrazino[2,3-h][3]benzazepine, 7,8,9,10-tetrahydro-8-(trifluoroacetyl)- (9CI)](https://qncdn.chemcd.cn/alchemypharm/AP10714.png "BK034N | 230615-70-0 | 6,10-Methano-6H-pyrazino[2,3-h][3]benzazepine, 7,8,9,10-tetrahydro-8-(trifluoroacetyl)- (9CI)")
Catalog No.: BK034N
CAS.RN：230615-70-0
Molecular Formula: C15H12F3N3O
Molecular Weight: 307.27 g/mol
Purity: NLT 98%
Intermediates of Varenicline
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA2R32 | Varenicline API | 249296-44-4 |
| BK8F0W | 2,3,4,5-Tetrahydro-7,8-dinitro-3-(trifluoroacetyl)-1,5-methano-1H-3-benzazepine | 230615-59-5 |
| BK8QY1 | 2,3,4,5-Tetrahydro-1H-1,5-methanobenzo[d]azepine Hydrochloride | 230615-52-8 |
| BK52N4 | 1,5-Methano-1H-3-benzazepine-7,8-diamine, 2,3,4,5-tetrahydro-3-(trifluoroacetyl)- (9CI) | 230615-69-7 |
| BK9GX5 | 1,4-Dihydro-1,4-methanonaphthalene | 4453-90-1 |
| BK034N | 6,10-Methano-6H-pyrazino[2,3-h][3]benzazepine, 7,8,9,10-tetrahydro-8-(trifluoroacetyl)- (9CI) | 230615-70-0 |
| BK736T | 1,4-Methanonaphthalene-2,3-diol, 1,2,3,4-tetrahydro- | 230615-47-1 |
| BK616S | Varenicline (Tartrate) | 375815-87-5 |
Products are offered for research, development, or industrial use only.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
